Witnessing the stock’s movement on the chart, on Thursday, Neumora Therapeutics Inc. (NASDAQ: NMRA) set off with pace as it heaved 1.68% to $16.96, before settling in for the price of $16.68 at the close. Taking a more long-term approach, NMRA posted a 52-week range of $8.33-$21.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 0.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 59.37%. This publicly-traded company’s shares outstanding now amounts to $158.83 million, simultaneously with a float of $54.91 million. The organization now has a market capitalization sitting at $2.71 billion. At the time of writing, stock’s 50-day Moving Average stood at $12.62, while the 200-day Moving Average is $12.82.
Neumora Therapeutics Inc. (NMRA) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Neumora Therapeutics Inc.’s current insider ownership accounts for 65.69%, in contrast to 27.62% institutional ownership. Preceding that transaction, on Oct 10 ’24, Company’s Head of R&D sold 8,260 for 15.09, making the whole transaction’s value amount to 124,603. This particular insider is now the holder of 314,706 in total.
Neumora Therapeutics Inc. (NMRA) Earnings and Revenue Records
Neumora Therapeutics Inc.’s EPS increase for this current 12-month fiscal period is 59.37% and is forecasted to reach -1.56 in the upcoming year.
Neumora Therapeutics Inc. (NASDAQ: NMRA) Trading Performance Indicators
Let’s observe the current performance indicators for Neumora Therapeutics Inc. (NMRA). It’s Quick Ratio in the last reported quarter now stands at 17.22. The Stock has managed to achieve an average true range (ATR) of 0.91.
In the same vein, NMRA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.74, a figure that is expected to reach -0.39 in the next quarter, and analysts are predicting that it will be -1.56 at the market close of one year from today.
Technical Analysis of Neumora Therapeutics Inc. (NMRA)
Going through the that latest performance of [Neumora Therapeutics Inc., NMRA]. Its last 5-days volume of 1.54 million indicated improvement to the volume of 0.67 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 93.95% While, its Average True Range was 0.97.
Raw Stochastic average of Neumora Therapeutics Inc. (NMRA) in the period of the previous 100 days is set at 98.40%, which indicates a major rise in contrast to 96.85% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 49.41% that was lower than 54.70% volatility it exhibited in the past 100-days period.
